Enzalutamide


CAS No. : 915087-33-1

(Synonyms: MDV3100)

915087-33-1
Price and Availability of CAS No. : 915087-33-1
Size Price Stock
5mg $50 In-stock
10mg $70 In-stock
25mg $95 In-stock
50mg $120 In-stock
100mg $190 In-stock
200mg $240 In-stock
500mg $350 In-stock
1g $540 In-stock
2g $730 In-stock
5g $1180 In-stock
10 g Get quote
50 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-70002
M.Wt: 464.44
Formula: C21H16F4N4O2S
Purity: >98 %
Solubility: DMSO : ≥ 50 mg/mL
Introduction of 915087-33-1 :

Enzalutamide (MDV3100) is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells. Enzalutamide is an autophagy activator[1][2]. IC50 & Target:IC50: 36 nM (androgen-receptor, in LNCaP cells)[1] In Vitro:Enzalutamide (MDV3100) has greater affinity to AR than ICI 176334 does in a competition assay with 16β-[18F]fluoro-5α-DHT (18-FDHT) in castration-resistant LNCaP/AR cells (AR-overexpressing). While Enzalutamide shows no agonism in LNCaP/AR prostate cells. Enzalutamide antagonizes induction of prostate-specific antigen (PSA) and transmembrane serine protease 2 (TMPRSS2), combination with the synthetic androgen R1881 in parental LNCaP cells. Enzalutamide inhibits the transcriptional activity of a mutant AR protein (W741C, mutation of Trp741 to Cys)[1].
Enzalutamide also prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex[2]. In Vivo:Enzalutamide (MDV3100) induces great tumor regression in castrate male mice bearing LNCaP/AR xenografts at a dose of 10 mg/kg[1].
Enzalutamide shows dose-independent pharmacokinetics at intravenous and oral doses of 0.5-5 mg/kg[4].

Your information is safe with us.